196 related articles for article (PubMed ID: 24331148)
1. Current readings: the most influential and recent studies regarding resection of lung cancer in m1a disease.
Mordant P; Rivera C; Legras A; Le Pimpec Barthes F; Riquet M
Semin Thorac Cardiovasc Surg; 2013; 25(3):251-5. PubMed ID: 24331148
[TBL] [Abstract][Full Text] [Related]
2. Primary tumour resection showed survival benefits for non-small-cell lung cancers with unexpected malignant pleural dissemination.
Ren YJ; She YL; Dai CY; Jiang GN; Fei K; Chen C
Interact Cardiovasc Thorac Surg; 2016 Mar; 22(3):321-6. PubMed ID: 26705302
[TBL] [Abstract][Full Text] [Related]
3. [The place of surgery in metastatic non-small cell lung cancer].
Le Pimpec Barthes F; Mordant P; Pricopi C; Foucault C; Dujon A; Riquet M
Rev Mal Respir; 2012 Mar; 29(3):376-83. PubMed ID: 22440301
[TBL] [Abstract][Full Text] [Related]
4. Survival of M1a Non-Small Cell Lung Cancer Treated Surgically: A Retrospective Single-Center Study.
Liu T; Liu H; Wang G; Zhang C; Liu B
Thorac Cardiovasc Surg; 2015 Oct; 63(7):577-82. PubMed ID: 25893920
[TBL] [Abstract][Full Text] [Related]
5. Preoperative concurrent chemoradiotherapy followed by extrapleural pneumonectomy for patients with non-small cell lung cancer with malignant pleural effusion and/or pleural nodules: Ten-year results of a prematurely terminated single institute phase II trial.
Yamaguchi M; Ichinose Y; Shimamatsu S; Yoshida T; Toyokawa G; Nosaki K; Hirai F; Seto T; Takenoyama M
Surg Oncol; 2015 Jun; 24(2):78-83. PubMed ID: 25818753
[TBL] [Abstract][Full Text] [Related]
6. The prognosis after contraindicated surgery of NSCLC patients with malignant pleural effusion (M1a) may be better than expected.
Ren Y; Dai C; Shen J; Liu Y; Xie D; Zheng H; He J; Liang W; Jiang G; Fei K; Yang P; He J; Chen C
Oncotarget; 2016 May; 7(18):26856-65. PubMed ID: 27057627
[TBL] [Abstract][Full Text] [Related]
7. Prognosis of non-small-cell lung cancer patients with positive pleural lavage cytology.
Nakao M; Hoshi R; Ishikawa Y; Matsuura Y; Uehara H; Mun M; Nakagawa K; Okumura S
Interact Cardiovasc Thorac Surg; 2015 Jun; 20(6):777-82. PubMed ID: 25762707
[TBL] [Abstract][Full Text] [Related]
8. Effects of a simple intraoperative intrathoracic hyperthermotherapy for lung cancer with malignant pleural effusion or dissemination.
Kimura M; Tojo T; Naito H; Nagata Y; Kawai N; Taniguchi S
Interact Cardiovasc Thorac Surg; 2010 Apr; 10(4):568-71. PubMed ID: 20093263
[TBL] [Abstract][Full Text] [Related]
9. Surgery for metastatic pleural extension of non-small-cell lung cancer.
Mordant P; Arame A; Foucault C; Dujon A; Le Pimpec Barthes F; Riquet M
Eur J Cardiothorac Surg; 2011 Dec; 40(6):1444-9. PubMed ID: 21515066
[TBL] [Abstract][Full Text] [Related]
10. [Curative surgical treatment options for patients with non-small cell lung cancer (NSCLC) and solitary pulmonary metastasis].
Tönnies M; Kollmeier J; Bauer TT; Griff S; Kaiser D
Pneumologie; 2012 Apr; 66(4):218-23. PubMed ID: 22477482
[TBL] [Abstract][Full Text] [Related]
11. [Surgical treatment of lung cancer with carcinomatous pleuritis].
Yokoi K; Matsuguma H
Nihon Geka Gakkai Zasshi; 2013 Jul; 114(4):196-200. PubMed ID: 23898708
[TBL] [Abstract][Full Text] [Related]
12. Tumor, node and metastasis classification of lung cancer--M1a versus M1b--analysis of M descriptors and other prognostic factors.
Sánchez de Cos Escuín J; Abal Arca J; Melchor Íñiguez R; Miravet Sorribes L; Núñez Ares A; Hernández Hernández JR; García Arangüena L; Núñez Delgado M; Pavón Fernández MJ; Francisco Corral G; de Esteban Júlvez L; González Budiño MT; Abad Cavaco F; Ansótegui Barrera E; Andreo García F; Serra Mitjans M; Hernández Rodríguez H
Lung Cancer; 2014 May; 84(2):182-9. PubMed ID: 24629637
[TBL] [Abstract][Full Text] [Related]
13. In lung cancer patients where a malignant pleural effusion is found at operation could resection ever still be justified?
Fiorelli A; Santini M
Interact Cardiovasc Thorac Surg; 2013 Aug; 17(2):407-12. PubMed ID: 23656925
[TBL] [Abstract][Full Text] [Related]
14. Long-Term Survival of American Joint Committee on Cancer 8th Edition Staging Descriptors for Clinical M1a Non-Small Cell Lung Cancer.
Kumar A; Xu B; Srinivasan D; Potter AL; Raman V; Lanuti M; Yang CJ; Auchincloss HG
Chest; 2024 Mar; 165(3):725-737. PubMed ID: 37544427
[TBL] [Abstract][Full Text] [Related]
15. Visceral pleural invasion classification in non-small cell lung cancer: a proposal on the basis of outcome assessment.
Shimizu K; Yoshida J; Nagai K; Nishimura M; Yokose T; Ishii G; Nishiwaki Y
J Thorac Cardiovasc Surg; 2004 Jun; 127(6):1574-8. PubMed ID: 15173709
[TBL] [Abstract][Full Text] [Related]
16. Risk factor analysis of locoregional recurrence after sublobar resection in patients with clinical stage IA non-small cell lung cancer.
Koike T; Koike T; Yoshiya K; Tsuchida M; Toyabe S
J Thorac Cardiovasc Surg; 2013 Aug; 146(2):372-8. PubMed ID: 23870323
[TBL] [Abstract][Full Text] [Related]
17. N1 non-small-cell lung cancer. A 20-year surgical experience.
Casali C; Stefani A; Morandi U
Asian Cardiovasc Thorac Ann; 2011 Jun; 19(3-4):217-24. PubMed ID: 21885545
[TBL] [Abstract][Full Text] [Related]
18. Pleural lavage cytology before and after lung resection in non-small cell lung cancer patients.
Enatsu S; Yoshida J; Yokose T; Nishimura M; Nishiwaki Y; Shirakusa T; Nagai K
Ann Thorac Surg; 2006 Jan; 81(1):298-304. PubMed ID: 16368385
[TBL] [Abstract][Full Text] [Related]
19. Impact of tumor size on outcomes after anatomic lung resection for stage 1A non-small cell lung cancer based on the current staging system.
Carr SR; Schuchert MJ; Pennathur A; Wilson DO; Siegfried JM; Luketich JD; Landreneau RJ
J Thorac Cardiovasc Surg; 2012 Feb; 143(2):390-7. PubMed ID: 22169444
[TBL] [Abstract][Full Text] [Related]
20. The revised TNM staging system for lung cancer.
Rami-Porta R; Crowley JJ; Goldstraw P
Ann Thorac Cardiovasc Surg; 2009 Feb; 15(1):4-9. PubMed ID: 19262443
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
